Related Experiment Video

Updated: Aug 15, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Cancer proteomics: many technologies, one goal

Thomas P Conrads1, Brian L Hood, Emmanuel F Petricoin

  • 1Laboratory of Proteomics & Analytical Technologies, SAIC-Frederick Inc., National Cancer Institute, Frederick, MD 21702, USA. conrads@ncifcrf.gov

Expert Review of Proteomics
|October 8, 2005
PubMed

Insights

The National Cancer Institute is using advanced proteomic technologies to find cancer biomarkers in patient samples. This multi-pronged approach aims to improve diagnostics and reduce cancer deaths.

Area of Science:

  • Biochemistry
  • Oncology
  • Biotechnology

Background:

  • The National Cancer Institute aims to reduce cancer morbidity and mortality by 2015.
  • Proteomic technologies offer powerful tools for biomarker discovery in biological samples.
  • The -omics era has accelerated the potential for comprehensive biological sample analysis.

Purpose of the Study:

  • To review the National Cancer Institute's multipronged approach to identifying disease-specific biomarkers.
  • To discuss the role of proteomic technologies in achieving the National Cancer Institute's 2015 goal.
  • To highlight the potential of novel diagnostics and therapeutics derived from biomarker discovery.

Main Methods:

  • Leveraging data-gathering capabilities of proteomic technologies.
  • Surveying biological samples (serum, plasma, urine, tissues) for biomarkers.
  • Employing a multipronged research strategy to identify specific biomarkers.

Main Results:

  • Proteomic technologies enable unprecedented analysis of biological samples for biomarkers.
  • Identifying disease-specific biomarkers is crucial for developing new diagnostics and therapeutics.
  • The optimal proteomic technologies for biomarker discovery are still under investigation.

Conclusions:

  • A multipronged approach is essential for effective biomarker discovery in cancer research.
  • Proteomic technologies are key to advancing cancer diagnostics and therapeutics.
  • Continued research is needed to determine the most successful proteomic strategies for biomarker identification.

More Related Videos

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry06:51

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.